Christian S. Michel

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Erratum: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 08, 2026

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2026

Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial.

Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial.

Journal: Leukemia
Published: March 21, 2026

Disseminated Strongyloides stercoralis Infection Diagnosed by Metagenomic Next-Generation Sequencing of a Cell-Free DNA blood sample in a Patient with Hematologic Malignancy in Germany: A Case Report.

Disseminated Strongyloides stercoralis Infection Diagnosed by Metagenomic Next-Generation Sequencing of a Cell-Free DNA blood sample in a Patient with Hematologic Malignancy in Germany: A Case Report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 01, 2026

Disseminated Strongyloides stercoralis infection diagnosed by metagenomic next-generation sequencing of a cell-free DNA blood sample in a patient with hematologic malignancy in Germany: A case report.

Disseminated Strongyloides stercoralis infection diagnosed by metagenomic next-generation sequencing of a cell-free DNA blood sample in a patient with hematologic malignancy in Germany: A case report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 01, 2026

Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancy.

Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancy.

Journal: Frontiers in oncology
Published: January 10, 2026

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Journal: Leukemia
Published: October 28, 2025

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Journal: Blood
Published: October 03, 2025

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Journal: Blood
Published: October 03, 2025

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Journal: Leukemia
Published: August 01, 2025

Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

Journal: European journal of haematology
Published: July 07, 2025

Prospective systematic classification of causes of death in the course of multiple myeloma.

Prospective systematic classification of causes of death in the course of multiple myeloma.

Journal: Blood cancer journal
Published: July 02, 2025
Showing 1-12 of 47

Last Updated: 09/26/2026